Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Capital Work in Progress

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹151 Cr₹238 Cr₹177 Cr₹181 Cr₹338 Cr

What is the latest Capital Work in Progress ratio of GLAND PHARMA ?

The latest Capital Work in Progress ratio of GLAND PHARMA is ₹151 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹151 Cr
Mar2024₹238 Cr
Mar2023₹177 Cr
Mar2022₹181 Cr
Mar2021₹338 Cr

How is Capital Work in Progress of GLAND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹151 Cr
-36.71
Mar2024 ₹238 Cr
34.23
Mar2023 ₹177 Cr
-1.95
Mar2022 ₹181 Cr
-46.49
Mar2021 ₹338 Cr -

Compare Capital Work in Progress of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,372.8 Cr 1% 1.9% 1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,147.0 Cr -2.1% -7.7% -9.7% Stock Analytics
DIVIS LABORATORIES ₹161,208.0 Cr -2.6% -6.8% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,190.0 Cr 0.1% 5.5% 25.3% Stock Analytics
CIPLA ₹110,790.0 Cr -1.9% -9.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,587.0 Cr 3.5% -5.2% -11.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1%

1.9%

1%

SENSEX

-1.3%

-3.1%

6.8%


You may also like the below Video Courses